Iovance Biotherapeutics Highlights Business Achievements, Pipeline Milestones, and Third ...

Quarterly Revenue Growth of 13% to ~$68 Million Gross Margin Increased to 43% on Improved Execution and Operational EfficiencyBest-in-Class ...